[HTML][HTML] Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate—Two randomized Phase II clinical trials in 18 to 49 …
S Pillet, J Couillard, S Trépanier, JF Poulin… - PloS one, 2019 - journals.plos.org
Background New influenza vaccines eliciting more effective protection are needed,
particularly for the elderly who paid a large and disproportional toll of hospitalization and …
particularly for the elderly who paid a large and disproportional toll of hospitalization and …
Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate—Two randomized Phase II clinical trials in 18 to 49 and≥ 50 …
S Pillet, J Couillard, S Trépanier, JF Poulin… - PLoS …, 2019 - search.ebscohost.com
Background: New influenza vaccines eliciting more effective protection are needed,
particularly for the elderly who paid a large and disproportional toll of hospitalization and …
particularly for the elderly who paid a large and disproportional toll of hospitalization and …
Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate-Two randomized Phase II clinical trials in 18 to 49 and …
S Pillet, J Couillard, S Trepanier, JF Poulin… - PLoS ONE, 2019 - go.gale.com
Background New influenza vaccines eliciting more effective protection are needed,
particularly for the elderly who paid a large and disproportional toll of hospitalization and …
particularly for the elderly who paid a large and disproportional toll of hospitalization and …
[引用][C] Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate—Two randomized Phase II clinical trials in 18 to 49 …
S Pillet, J Couillard, S Trépanier, JF Poulin… - PLOS ONE, 2019 - cir.nii.ac.jp
Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine
candidate—Two randomized Phase II clinical trials in 18 to 49 and ≥50 years old adults | CiNii …
candidate—Two randomized Phase II clinical trials in 18 to 49 and ≥50 years old adults | CiNii …
Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate-Two randomized Phase II clinical trials in 18 to 49 and≥ 50 …
S Pillet, J Couillard, S Trépanier, JF Poulin… - Plos one, 2019 - europepmc.org
Background New influenza vaccines eliciting more effective protection are needed,
particularly for the elderly who paid a large and disproportional toll of hospitalization and …
particularly for the elderly who paid a large and disproportional toll of hospitalization and …
[引用][C] Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate—Two randomized Phase II clinical trials in 18 to 49 …
S Pillet, J Couillard, S Trépanier, JF Poulin… - PLoS …, 2019 - ui.adsabs.harvard.edu
Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine
candidate—Two randomized Phase II clinical trials in 18 to 49 and ≥50 years old adults …
candidate—Two randomized Phase II clinical trials in 18 to 49 and ≥50 years old adults …
Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate-Two randomized Phase II clinical trials in 18 to 49 and≥ 50 …
S Pillet, J Couillard, S Trépanier, JF Poulin… - PloS …, 2019 - pubmed.ncbi.nlm.nih.gov
Background New influenza vaccines eliciting more effective protection are needed,
particularly for the elderly who paid a large and disproportional toll of hospitalization and …
particularly for the elderly who paid a large and disproportional toll of hospitalization and …
[HTML][HTML] Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate—Two randomized Phase II clinical trials in 18 to 49 …
S Pillet, J Couillard, S Trépanier, JF Poulin… - PLoS ONE, 2019 - ncbi.nlm.nih.gov
Background New influenza vaccines eliciting more effective protection are needed,
particularly for the elderly who paid a large and disproportional toll of hospitalization and …
particularly for the elderly who paid a large and disproportional toll of hospitalization and …
[PDF][PDF] Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate—Two randomized Phase II clinical trials in 18 to 49 …
S Pillet, J Couillard, S Trépanier, JF Poulin… - PLoS …, 2019 - pdfs.semanticscholar.org
Background New influenza vaccines eliciting more effective protection are needed,
particularly for the elderly who paid a large and disproportional toll of hospitalization and …
particularly for the elderly who paid a large and disproportional toll of hospitalization and …
Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate-two randomized Phase II clinical trials in 18 to 49 and≥ 50 …
S Pillet, J Couillard, S Trépanier, JF Poulin… - 2019 - cabidigitallibrary.org
Background: New influenza vaccines eliciting more effective protection are needed,
particularly for the elderly who paid a large and disproportional toll of hospitalization and …
particularly for the elderly who paid a large and disproportional toll of hospitalization and …